Document Detail

Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
MedLine Citation:
PMID:  22402936     Owner:  NLM     Status:  Publisher    
The pathogenic mechanisms of thromboangiitis obliterans (TAO) are not entirely known and the imbalance of matrix metalloproteinases (MMPs) plays a role in vascular diseases. We evaluated the MMP-2 and MMP-9 circulating levels and their endogenous tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in TAO patients with clinical manifestations. The study included 20 TAO patients (n = 10 female, n = 10 male) aged 38-59 years under clinical follow-up. The patients were classified into two groups: (1) TAO former smokers (n = 11) and (2) TAO active smokers (n = 9); the control group included normal volunteer non-smokers (n = 10) and active smokers without peripheral artery disease (n = 10). Patient plasma samples were used to analyze MMP-2 and MMP-9 levels using zymography, and TIMP-1 and TIMP-2 concentrations were determined by enzyme-linked immunosorbent assays. The analysis of MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios (which were used as indices of net MMP-2 and MMP-9 activity, respectively) showed significantly higher MMP-9/TIMP-1 ratios in TAO patients (p < 0.05). We found no significant differences in MMP-2/TIMP-2 ratios (p > 0.05). We found higher MMP-9 levels and decreased levels of TIMP-1 in the TAO groups (active smokers and former smokers), especially in active smokers compared with the other groups (all p < 0.05). MMP-2 and TIMP-2 were not significantly different in patients with TAO as compared to the control group (p > 0.05). In conclusion, our results showed increased MMP-9 and reduced TIMP-1 activity in TAO patients, especially in active smokers compared with non-TAO patients. These data suggest that smoke compounds could activate MMP-9 production or inhibit TIMP-1 activity.
Renata Dellalibera-Joviliano; Anna Lb Jacob-Ferreira; Edwaldo Edner Joviliano; José E Tanus-Santos; Paulo R B Evora
Related Documents :
20086106 - Clinical presentation of endometrioid epithelial ovarian cancer with concurrent endomet...
21352216 - Bronchial hyper-reactivity in migraine without aura: is it a new clue for inflammation?
12470406 - The effects of one- and two-stage orchiopexy on postoperative serum testosterone levels...
2501336 - Inhibin and renin in follicular fluids of patients with one or two ovaries stimulated w...
9012696 - Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a...
3101166 - Duodenal, prepyloric, and combined duodenal/prepyloric ulcer disease: three distinct en...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-8
Journal Detail:
Title:  Vascular medicine (London, England)     Volume:  -     ISSN:  1477-0377     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610930     Medline TA:  Vasc Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
University Center UNIFAFIBE, Bebedouro, SP, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aneurysm sac shrinkage after endovascular treatment of the aorta: beyond sac pressure and endoleaks.
Next Document:  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.